Literature DB >> 2156536

Epstein-Barr virus infection of epithelial cells derived from primary cultures of adenoidal tissue.

M Furukawa1, H Sakashita, C Kato, R Umeda.   

Abstract

Epithelial cells derived from primary cultures of adenoidal tissue were exposed to Epstein-Barr virus (EBV) from the throat washings of a patient with infectious mononucleosis (IM) and P3HR-1 and B95-8 cell strains. They were then examined for EBV-specific antigens by immunofluorescence. EBV from both the P3HR-1 cell strains and the throat washings of the IM patient infected the epithelial cells at the 6th and 9th days, respectively. Although the EBV-antigen-positive cells did not increase in number and disappeared at the 12th day after infection, EBV antigens of the virus's replication cycle could still be detected in the epithelial cells shed from cell culture layer at this time. However, the virus obtained from the cell-free 12th day's culture medium was incapable of transforming cord blood lymphocytes.

Entities:  

Mesh:

Year:  1990        PMID: 2156536     DOI: 10.1007/BF00183179

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  19 in total

1.  Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups.

Authors:  W Henle; G Henle; H C Ho; P Burtin; Y Cachin; P Clifford; A de Schryver; G de-Thé; V Diehl; G Klein
Journal:  J Natl Cancer Inst       Date:  1970-01       Impact factor: 13.506

2.  Replication of EBV in epithelial cells during infectious mononucleosis.

Authors:  S M Lemon; L M Hutt; J E Shaw; J L Li; J S Pagano
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

3.  EB viral genomes in epithelial nasopharyngeal carcinoma cells.

Authors:  H Wolf; H zur Hausen; V Becker
Journal:  Nat New Biol       Date:  1973-08-22

4.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

5.  Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs.

Authors:  B Strauch; L L Andrews; N Siegel; G Miller
Journal:  Lancet       Date:  1974-02-16       Impact factor: 79.321

6.  Epstein-Barr virus (EBV) infection by cocultivation of fibroblast-dominant cell line and EBV-transformed lymphocytes.

Authors:  M Furukawa; M Kamide; T Miwa; M Sakumoto; R Umeda
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1989       Impact factor: 1.538

7.  Epstein-Barr virus receptors on human pharyngeal epithelia.

Authors:  L S Young; D Clark; J W Sixbey; A B Rickinson
Journal:  Lancet       Date:  1986-02-01       Impact factor: 79.321

8.  Infection of normal human epithelial cells by Epstein-Barr virus.

Authors:  I M Shapiro; D J Volsky
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

9.  Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx.

Authors:  G Klein; B C Giovanella; T Lindahl; P J Fialkow; S Singh; J S Stehlin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

10.  Pleiotropic expression of Epstein--Barr virus DNA in human epithelial cells.

Authors:  J Stoerker; D Parris; Y Yajima; R Glaser
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

View more
  1 in total

1.  Epstein-Barr virus gene expression and epithelial cell differentiation in oral hairy leukoplakia.

Authors:  J A Thomas; D H Felix; D Wray; J C Southam; H A Cubie; D H Crawford
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.